HOME >> BIOLOGY >> NEWS
UNC HIV-AIDS screening, prevention method could become national model for cutting illness

also are tested individually through what's called polymerase chain reaction (PCR).

"So far, we have tested about 50,000 patients, and the most important thing we have observed is that a significant number of very contagious infections are right now being missed by routine antibody testing," Pilcher said.

In addition, he said, patients can potentially benefit themselves if doctors know to start them quickly and aggressively on anti-retroviral treatment. Several preliminary studies have shown recently that early treatment may improve their long-term prognosis.

The detection of acute HIV infections can have important public health benefits as well, Pilcher said.

"Having the means to distinguish newly infected from long-ago infected individuals can reveal actual populations getting infected in something like real time and can provide guidance and feedback to the state's HIV prevention efforts."

Other medical scientists had suggested that the pooling technique could uncover individual new acute HIV cases among large groups of at-risk people, but the UNC investigators and their colleagues were the first to try the idea.

Other states have expressed interest in conducting similar screening. According to the JAMA article, the U.S. Centers for Disease Control and Prevention will award grants before long to study the feasibility of wider RNA screening across the country.


'"/>

Contact: David Williamson
919-962-8596
University of North Carolina at Chapel Hill
29-May-2003


Page: 1 2 3

Related biology news :

1. Researchers report definitive evidence that HIV-AIDS is not from oral polio vaccine
2. DNA biochip may lead to fast genetic screening, more effective drugs
3. Leader in cancer treatment and prevention research honored
4. OHSU researchers discover possible method for early detection, prevention of premature birth
5. Colleagues to recognize research leadership in cancer detection, prevention and treatment
6. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
7. Indoor mold, building dampness linked to respiratory problems and require better prevention
8. Insight into transplant rejection might lead to novel prevention therapies
9. Scientists making advances in cancer prevention, detection and treatment to receive awards
10. Oral drug showing promise for breast cancer prevention in a mouse model
11. Novel approaches to current cellular therapies continue progress toward disease prevention

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
Cached News: